Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung function changes related to diabetes mellitus.

Connie C W Hsia1, Philip Raskin

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9034, USA. Connie.Hsia@utsouthwestern.edu

Diabetes Technology & Therapeutics
|July 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary diffusing capacity for nitric oxide in disease: a scoping review.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.

Diabetes·2026
Same author

A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.

Obstetrical & gynecological survey·2025
Same author

Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes.

Diabetes care·2025
Same author

A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.

Obstetrical & gynecological survey·2025
Same author

Lung Function in a Multiethnic U.S. Cohort of Adolescents and Adults Born Preterm in the New BPD Era.

Pediatric pulmonology·2025
Same journal

Continuous Glucose Monitoring Metrics and Perinatal Outcomes in Pregnant Women with Type 2 Diabetes.

Diabetes technology & therapeutics·2026
Same journal

Invited Commentary: Using Large Clinical Databases.

Diabetes technology & therapeutics·2026
Same journal

Impact of Technology Introduction on Glycemic Control of People Living with Type 1 Diabetes in Belgium: An Observational, Real-World Study.

Diabetes technology & therapeutics·2026
Same journal

Differences in Achieving Stringent Glycemic Targets Among Youth with Type 1 Diabetes: A SWEET Registry Study.

Diabetes technology & therapeutics·2026
Same journal

<i>Letter:</i> "Nocturnal Hypoglycemia: Characterization with Continuous Glucose Monitoring in a Real-World Setting".

Diabetes technology & therapeutics·2026
Same journal

Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.

Diabetes technology & therapeutics·2026
See all related articles

Diabetic microangiopathy affects lung function, often subclinically. Pulmonary assessment is crucial for understanding disease progression and potential interactions with treatments like inhaled insulin.

Area of Science:

  • Pulmonary Medicine
  • Endocrinology
  • Diabetic Complications

Background:

  • Diabetic microangiopathy affects various organs, including the lungs.
  • Respiratory dysfunction in diabetes is typically subclinical but significant.

Purpose of the Study:

  • To review lung function changes in diabetes.
  • To discuss underlying mechanisms, physiological, and clinical implications.
  • To highlight the importance of pulmonary assessment in diabetic patients.

Main Methods:

  • Literature review of studies on diabetes and lung function.
  • Analysis of physiological mechanisms of microangiopathy in the lungs.
  • Discussion of clinical relevance and implications for inhaled therapies.

Related Experiment Videos

Main Results:

  • Pulmonary function tests offer noninvasive assessment of physiological reserves.
  • Subclinical pulmonary reserve loss can be debilitating under stress.
  • Lung function indices are largely independent of physical fitness and less complicated by diabetic sequelae.

Conclusions:

  • Lung function can serve as a marker for systemic microangiopathy progression.
  • Potential impact of inhaled insulin on pulmonary function requires consideration.
  • Preexisting lung conditions may affect inhaled insulin efficacy.